Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 18 Source: CRO
- €20 million turnover
-
€32.5 million
profit - 52 employees
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
- 3 more years available »
Ranking
By Turnover
(€20 million)- 882nd in Top Companies
- 95th in Health
By Employees
(52)- 828th in Top Companies
- 89th in Health
- 52
- €20 million
Employees
- Colm Healy Vice President}
Latest News
- 5:22pm Reads seeks injunction against Goodman family company over access to premises
- 5:01pm Electrical contractors could be hit by new pay law, court told
- 5:01pm Electrical contractors fear closure under new pay law
- 4:10pm Court hears of property fund’s drop in value following economic crash
- 4:10pm Investor alleges fraud over collapse in property fund value